The importance of new therapeutics in healthcare will continue to increase, which in turn will allow selected biotechnology activities to benefit handsomely. R, D, M fundamentals Despite my belief ...

Splitting up its R&D to create a biotech environment could shorten lines of communication, ease the decision-making process, and bring business management into the research end of GSK.

Against a backdrop of rising U.S.-China geopolitical tensions, there are signs of growing dealmaking activity between Western pharmaceutical companies and Chinese biotechs, multiple research firms ...